Texas Tech Unıversity, Health Sciences Center, USA
Dr. Sanjay K. Srivastava is a Distinguished Professor and Chairman of Department of Immunotherapeutics and Biotechnology at the Texas Tech University Health Sciences Center, Texas, USA. He is also the Associate Dean for Sciences at the same institution. Dr. Srivastava has published around 150 papers in high impact journals, numerous abstracts and book chapters, has several patents, and is the editor of three books on cancer. His research has been continuously funded by the National Cancer Institute, NIH. Dr. Srivastava is a recipient of several prestigious awards. His research work has been featured by news agencies including BBC, MSNBC, CBS, ABC, Science News, etc.
Dr. Srivastava’s laboratory has been working on pancreatic cancer, breast cancer, ovarian cancer, brain cancer and melanoma, and demonstrated that some of the dietary agents, such as piperlongumine, capsaicin, cucurbitacin B, benzyl isothiocyanate, phenethyl isothiocyanate, diindolylmethane and curcumin, suppress the growth of primary and metastatic tumors by inhibiting various oncogenic signaling pathways. The main theme of his research is directed towards understanding the mechanisms that underlie the cellular and molecular basis of cancer and evaluating novel anti-cancer agents against various types of cancers. Ongoing studies along these lines in Dr. Srivastava’s laboratory will identify novel targets to develop new therapies for cancer.